eISSN: 1644-4124
ISSN: 1426-3912
Central European Journal of Immunology
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
2/2022
vol. 47
 
Share:
Share:
abstract:
Experimental immunology

Generation of high cross-presentation ability human dendritic cells by combination of interleukin 4, interferon β and GM-CSF

Yihua Pi
1
,
Yifang Li
2
,
Rongyi Liang
1, 3
,
Jian Xiao
1, 3
,
Jing Leng
1, 3
,
Lifeng Zhang
1, 3

  1. Guangxi University of Chinese Medicine, China
  2. The Second People’s Hospital of Hunan Province, China
  3. Guangxi Key Laboratory of Translational Medicine for Treating High-Incidence Infectious Diseases with Integrative Medicine, China
Cent Eur J Immunol 2022; 47 (2): 125-138
Online publish date: 2022/07/04
View full text Get citation
 
PlumX metrics:
Dendritic cell (DC)-based immunotherapies have been utilized for the treatment of numerous diseases. However, the conventional generation strategies of DCs in vitro require 7 days and these DCs showed an unsatisfactory function, which prompted us to explore new approaches. We found that in vitro culture of human CD14+ cells, in the medium containing granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin (IL)-4, as well as interferon  (IFN-) for 48 h, followed by the maturation stimuli of IL-1 and poly I:C for another 24 h can be differentiated into high cross-presentation ability DCs (G4B-DCs). These DCs express high levels of CD11c, CD86, and HLA-DR, producing a high level of tumor necrosis factor  (TNF-). Of note, compared with the conventional DCs, G4B-DCs showed a higher ability to promote allogeneic naïve CD4+ T cell and CD8+ T cell proliferation and interferon (IFN)- production. These DCs also have the remarkable ability to induce Flu-M1-specific CD8+ T cells. In addition, we found that these G4B-DCs express partially the cDC1 phenotype. These data indicate that G4B-DC is unique and may provide a relatively rapid alternative method for potential clinical use.
keywords:

IL-4, dendritic cell, cDC1, cross-presentation, IFN-b

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.